FFL
NVO

Financial Freedom LLC’s Novo Nordisk NVO Stock Holding History

Financial Freedom LLC’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.22K Hold
115
– – ﹤0.01% 365
2025
Q4 		$5.85K Hold
115
– – ﹤0.01% 293
2025
Q3 		$6.38K Hold
115
– – ﹤0.01% 303
2025
Q2 		$7.93K Hold
115
– – ﹤0.01% 290
2025
Q1 		$7.98K Hold
115
– – ﹤0.01% 292
2024
Q4 		$9.89K Hold
115
– – 0.01% 274
2024
Q3 		$13.7K Hold
115
– – 0.01% 250
2024
Q2 		$16.4K Buy
+115
New +$15.2K 0.01% 237

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Financial Freedom LLC's NVO Position: Q1 2026 in Review

Financial Freedom LLC held its Novo Nordisk (NVO) position steady in Q1 2026 at 115 shares worth $4.22K. The position accounts for ﹤0.01% of the portfolio, ranked #365.

Financial Freedom LLC first reported a position in NVO in Q2 2024 and has held it in 8 quarters since. The position peaked at $16.4K in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Financial Freedom LLC held 115 shares of Novo Nordisk worth $4.22K as of Q1 2026.
  • Financial Freedom LLC left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up ﹤0.01% of Financial Freedom LLC's portfolio in Q1 2026, its #365 holding.
  • Financial Freedom LLC first reported a position in Novo Nordisk in Q2 2024 and has held it in 8 quarters since.
  • Financial Freedom LLC's Novo Nordisk position peaked at $16.4K in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Financial Freedom LLC's 13F filing for Q1 2026, filed 30 Apr 2026.